[144] BorgWarner Inc. SEC Filing

Rhea-AI Filing Summary

BorgWarner Inc. insider sale notice (Form 144) — This filing reports that an individual received 2,690 shares on 02/05/2025 from a performance stock lapse as equity compensation and intends to sell those 2,690 common shares on 08/28/2025 through Charles Schwab & Co., Inc. at an aggregate market value of $115,470 on the NYSE. The filing also discloses that the same person sold 5,000 shares on 08/04/2025 for $188,550 and 2,500 shares on 08/12/2025 for $100,025. The filer certifies no undisclosed material adverse information.

Positive

• Performance award vested: 2,690 shares received on 02/05/2025 as equity compensation, indicating compensation alignment with company equity.
• Disclosure compliance: Filing provides required transparency of intended and recent insider sales through Rule 144.

Negative

• Insider sales disclosed: 7,500 shares sold in August 2025 for aggregate gross proceeds of $288,575, which may attract investor attention.
• Planned resale: Intended sale of 2,690 shares on 08/28/2025 with an aggregate market value of $115,470.

Insights

Corporate Governance Expert

TL;DR: Routine insider sales and a scheduled sale of recently vested performance shares; no undisclosed material information stated.

The Form 144 documents an insider who received 2,690 shares via performance stock lapse on 02/05/2025 and plans a sale on 08/28/2025 through Charles Schwab. The filing also records two recent open-market dispositions totaling 7,500 shares with gross proceeds of $288,575. This is a disclosure of intended and recent sales required under Rule 144 and includes the standard representation that the seller is not aware of undisclosed material adverse information.

Securities Analyst

TL;DR: Transaction sizes are small relative to total outstanding shares; informational for trading transparency, limited market impact.

The notice shows the securities to be sold represent 2,690 shares versus 216,392,876 shares outstanding as listed in the form, and prior sales in August totaled 7,500 shares. The filing therefore meets Rule 144 disclosure requirements. No earnings or operational details are provided, so material valuation implications cannot be drawn from this form alone.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	2690	115470.00	216392876	08/28/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/05/2025	Performance Stock Lapse	BORGWARNER INC			2690	02/05/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Isabelle McKenzie 3850 HAMLIN RD. AUBURN HILLS MI 48326	BORGWARNER INC	08/04/2025	5000	188550.00
Isabelle McKenzie 3850 HAMLIN RD. AUBURN HILLS MI 48326	BORGWARNER INC	08/12/2025	2500	100025.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does BorgWarner (BWA) Form 144 report?

The Form 144 reports an insider who received 2,690 shares on 02/05/2025 via performance stock lapse and intends to sell those shares on 08/28/2025 through Charles Schwab; it also discloses two prior sales in August 2025 totaling 7,500 shares.

How many shares does the filer plan to sell and when?

The filer intends to sell 2,690 common shares approximately on 08/28/2025 on the NYSE, with an aggregate market value listed as $115,470.

What were the recent insider sales disclosed in the Form 144?

The filing shows sales of 5,000 shares on 08/04/2025 for $188,550 and 2,500 shares on 08/12/2025 for $100,025.

How large are these transactions relative to BorgWarner's outstanding shares?

The form lists 216,392,876 shares outstanding; the planned sale of 2,690 shares and recent August sales of 7,500 shares are immaterial relative to total outstanding shares as disclosed in the filing.

Was the acquisition of the 2,690 shares a purchase or compensation?

The 2,690 shares were acquired on 02/05/2025 by performance stock lapse and the nature of payment is listed as Equity Compensation.